BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
A new analysis by the Department of Health and Human Services’ Office of Inspector General found that drugmakers need more guidance from the Centers for Medicare & Medicaid Services on establishing an average sales price that determines reimbursements for Medicare Part B drugs, reports Fierce Healthcare. The review, released Jan. 3, comes amid concerns from physicians that reimbursements for Part B drugs are too low.
1. UnitedHealth reports significant data breach; personal health info compromised
2. Ex-NBA player Will Bynum sentenced in insurance fraud scandal
3. Illinois House passes governor’s 'Healthcare Protection Act’
4. UnitedHealth faces scrutiny over size, operations, and cyberattack
5. Analyst says Cigna, Humana share prices could put merger back on the table
6. Walmart to shut down health clinics due to unprofitability